Evidence map›Paper›PMID 40976890›Full record

ArticleCurrent medical imaging2025

Machine Learning based Radiomics from Multi-parametric Magnetic Resonance Imaging for Predicting Lymph Node Metastasis in Cervical Cancer.

Jing Liu, Mingxuan Zhu, Li Li, Lele Zang, Lan Luo, Fei Zhu, Huiqi Zhang, Qin Xu

Abstract read
In one paragraph

Article in Current medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jing LiuDepartments of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (Fujian Branch of Fudan University Shanghai Cancer Center), Fuzhou 350014, Fujian, China.ORCID 0009-0001-5132-7236
Mingxuan ZhuDepartments of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (Fujian Branch of Fudan University Shanghai Cancer Center), Fuzhou 350014, Fujian, China.ORCID 0009-0000-5829-9437
Li LiDepartments of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (Fujian Branch of Fudan University Shanghai Cancer Center), Fuzhou 350014, Fujian, China.ORCID 0009-0003-4108-4642
Lele ZangDepartments of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (Fujian Branch of Fudan University Shanghai Cancer Center), Fuzhou 350014, Fujian, China.ORCID 0000-0002-4151-3182
Lan LuoDepartments of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (Fujian Branch of Fudan University Shanghai Cancer Center), Fuzhou 350014, Fujian, China.ORCID 0009-0006-9737-427X
Fei ZhuDepartments of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (Fujian Branch of Fudan University Shanghai Cancer Center), Fuzhou 350014, Fujian, China.ORCID 0009-0008-7386-9125
Huiqi ZhangDepartments of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (Fujian Branch of Fudan University Shanghai Cancer Center), Fuzhou 350014, Fujian, China.ORCID 0009-0003-9444-4090
Qin XuDepartments of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (Fujian Branch of Fudan University Shanghai Cancer Center), Fuzhou 350014, Fujian, China.ORCID 0000-0002-3689-0266

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionConstruct and compare multiple machine learning models to predict lymph node (LN) metastasis in cervical cancer, utilizing radiomic features extracted from preoperative multi-parametric magnetic resonance imaging (MRI).

methodsThis study retrospectively enrolled 407 patients with cervical cancer who were randomly divided into a training cohort (n=284) and a validation cohort (n=123). A total of 4065 radiomic features were extracted from the tumor regions of interest on contrast-enhanced T1-weighted imaging, T2-weighted imaging, and diffusion-weighted imaging for each patient. The Mann-Whitney U test, Spearman correlation analysis, and selection operator Cox regression analysis were employed for radiomic feature selection. The relationship between MRI radiomic features and LN status was analyzed using five machine-learning algorithms. Model performance was evaluated by measuring the area under the receiver-operating characteristic curve (AUC) and accuracy (ACC). Moreover, Kaplan-Meier analysis was used to validate the prognostic value of selected clinical and radiomic characteristics.

resultsLN metastasis was pathologically detected in 24.3% (99/407) of patients. Following a three-step feature selection, 18 radiomic features were employed for model construction. The XGBoost model exhibited superior performance compared to other models, achieving an AUC, accuracy, sensitivity, specificity, and F1 score of 0.9268, 0.8969, 0.7419, 0.9891, and 0.8364, respectively, on the validation set. Additionally, Kaplan-Meier curves indicated a significant correlation between radiomic scores and progression-free survival in cervical cancer patients (p < 0.05). DISCUSSION: Among the machine learning models, XGBoost demonstrated the best predictive ability for LN metastasis and showed prognostic value through its radiomic score, highlighting its clinical potential.

conclusionMachine learning-based multi-parametric MRI radiomic analysis demonstrated promising performance in the preoperative prediction of LN metastasis and clinical prognosis in cervical cancer.

Indexed as

Cervical cancerLymph node metastasisMachine learningMagnetic resonance imaging.

Identifiers

PMID40976890
PMCPMC13096877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.